Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




MicroRNA Deficiency Points to Increased Lung Cancer Risk

By LabMedica International staff writers
Posted on 06 Nov 2013
A species of microRNA (miRNA) has been identified that acts as a regulator for the normal development of airway epithelial tissue but is less abundant in individuals, especially smokers, who had developed lung cancer.

MiRNAs are snippets of about 20 nucleotides that block gene expression by attaching to molecules of messenger RNA (mRNA) in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA.

Investigators at the Boston University School of Medicine (MA, USA) used next-generation sequencing of small RNAs in the airway to identify microRNA 4423 (miR-4423) as a primate-specific miRNA associated with lung cancer. More...
MiR-4423 was expressed primarily in the mucociliary epithelium.

Results of the study linked abundant levels of miR-4423 to normal cell growth and differentiation, while its lack was linked to cancer development. For example, the endogenous expression of miR-4423 increased as bronchial epithelial cells underwent differentiation into mucociliary epithelium in vitro, and its overexpression during this process caused an increase in the number of ciliated cells. Expression of miR-4423 was reduced in most lung tumors and in cytologically normal epithelium of the mainstem bronchus of smokers with lung cancer. In addition, expression of miR-4423 in a subset of lung cancer-cell lines reduced their anchorage-independent growth and significantly decreased the size of the tumors formed in a mouse xenograft model. Finally, overexpression of miR-4423 induced a differentiated-like pattern of airway epithelium-gene expression and reversed the expression of many genes that are altered in lung cancer.

"These results suggest measuring the levels of microRNAs like miR-4423 in cells that line the airway could aid in lung cancer detection through a relatively noninvasive procedure," said senior author Dr. Avrum Spira, professor of medicine at the Boston University School of Medicine.

The study was published in the October 24, 2013, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS).

Related Links:
Boston University School of Medicine



Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Homocysteine Quality Control
Liquichek Homocysteine Control
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.